QGEN Qiagen Nv

Qiagen NV provides sample and assay technologies to extract, purify, amplify, and interpret DNA (Deoxyribonucleic acid), RNA (Ribonucleic acid), and proteins. It also offers kits, assays, related automated systems and bioinformatics solutions.

$46.45  +0.30 (0.65%)
As of 03/27/2023 14:23:01 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  The Netherlands
Country of incorporation:  The Netherlands
IPO date:  03/02/2001
Outstanding shares:  227,716,433
Average volume:  742,989
Market cap:   $10,436,244,124
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BYXS688

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%